Synergy CHC (SNYR) investor relations material

Company overview and business model

• Operates in consumer health care, beauty, and lifestyle products, with key brands FOCUSfactor (brain health supplement) and Flat Tummy (wellness products for women).

• Products are sold through major retailers (Costco, Amazon, Walmart, Walgreens, BJ's, The Vitamin Shoppe) and direct-to-consumer channels.

• Employs an asset-light model, partnering with third-party manufacturers for scalability and flexibility.

• Focuses on brand management, marketing, product development, and distribution, with a strategy to expand internationally and through new product launches.

Financial performance and metrics

• 2025 revenue was $30.4 million, net loss was $(12.3) million, and EBITDA was $(6.2) million, compared to 2024 revenue of $34.8 million, net income of $2.1 million, and EBITDA of $6.5 million.

• 2025 EBITDA decrease attributed to one-time items, including a $6.7 million bad debt reserve and $0.9 million inventory write-off.

• Working capital improved from a deficit of $1.1 million at end of 2024 to a surplus of $1.8 million at end of 2025.

• FOCUSfactor accounted for 92% of 2025 net revenue; Flat Tummy accounted for 8%.

Use of proceeds and capital allocation

• May receive up to $36 million in gross proceeds under the ELOC Purchase Agreement, to be used for working capital and general corporate purposes.

• Management retains broad discretion over allocation of proceeds, which may include strategic opportunities such as acquisitions or joint ventures.